Australian Clinical Labs
ACL.AX
#7919
Rank
โ‚น28.15 B
Marketcap
โ‚น146.49
Share price
2.26%
Change (1 day)
-10.29%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2025: โ‚น44.07 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is โ‚น44.07 Billion. In 2025 the company made a revenue of โ‚น44.07 Billion an increase over the revenue in the year 2024 that were of โ‚น41.90 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2025

Annual revenue

Year Revenue Change
2025โ‚น44.07 B5.2%
2024โ‚น41.90 B-0.2%
2023โ‚น41.98 B-32.41%
2022โ‚น62.11 B41.91%
2021โ‚น43.76 B